Tokyo Wellness Impact Fund Invests in HICKY, Inc., Developer of Central Sleep Apnea Treatment Device
NQ Score
50/100
AI Summary (NQ-processed)
The Tokyo Wellness Impact Fund has invested in HICKY, Inc., a startup developing an innovative stent-type device to treat central sleep apnea (CSA) in heart failure patients. The investment aims to support the development of technology that reduces procedural complexity and eliminates the need for battery-replacement surgeries, thereby improving patient outcomes.
AI analysis data is not yet available.